MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$9,325K
Net Income
-$62,045K
Net Profit Margin
-665.36%
EPS
-$0.93
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
9,325
6,229
1,402
10,632
Research and development
49,501
39,673
41,695
37,696
Sales, general and administrative
25,253
19,974
21,146
16,027
Total operating expenses
74,754
59,647
62,841
53,723
(loss) income from operations
-65,429
-53,418
-61,439
-43,091
Interest income (expense), net
3,503
3,397
3,615
3,463
Other income
308
18
-110
3
Total other income (expense)
3,811
3,415
3,505
3,466
(loss) income before income taxes
-61,618
-50,003
-
-39,625
Provision for income taxes
0
0
-
-1,278
Net (loss) income
-61,618
-50,003
-57,934
-38,347
Unrealized (loss) gain on marketable securities
-427
-658
97
350
Total other comprehensive (loss) gain
-427
-658
97
350
Comprehensive (loss) income
-62,045
-50,661
-57,837
-37,997
Basic EPS
-0.93
-0.79
-0.932
-0.65
Diluted EPS
-0.93
-0.79
-0.956
-0.65
Basic Average Shares
66,017,895
63,063,507
62,048,530
58,611,677
Diluted Average Shares
66,017,895
63,063,507
60,512,604
58,611,677
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (loss) income
-$62,045K
(-166.48%↓ Y/Y)
Net (loss) income
-$61,618K
(-162.39%↓ Y/Y)
Total other
comprehensive (loss) gain
-$427K
(-313.50%↓ Y/Y)
Interest income
(expense), net
$3,503K
(-7.55%↓ Y/Y)
Other income
$308K
(1000.00%↑ Y/Y)
(loss) income before
income taxes
-$61,618K
(-162.39%↓ Y/Y)
Unrealized (loss) gain on
marketable securities
-$427K
(-313.50%↓ Y/Y)
Total other income
(expense)
$3,811K
(-0.16%↓ Y/Y)
(loss) income from
operations
-$65,429K
(-139.67%↓ Y/Y)
Revenue
$9,325K
(-32.51%↓ Y/Y)
Total operating
expenses
$74,754K
(81.81%↑ Y/Y)
Research and development
$49,501K
(91.46%↑ Y/Y)
Sales, general and
administrative
$25,253K
Buy us a coffee
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)